Identification of an organic onion transport system in the human colon carcinoma cell line HT29 clone 19A

被引:28
作者
Abrahamse, SL
Rechkemmer, G
机构
[1] Acad Med Ctr, Surg Lab IWO 1 155, NL-1105 AZ Amsterdam, Netherlands
[2] IPF, Lower Saxony Inst Peptide Res, D-30625 Hannover, Germany
[3] Fed Res Ctr Nutr, Inst Nutr Physiol, D-76131 Karlsruhe, Germany
来源
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 2001年 / 441卷 / 04期
关键词
epithelium; fluo-3; intestine; multidrug resistance; sulfinpyrazone;
D O I
10.1007/s004240000437
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The human colon carcinoma cell line HT29 cl, 19A was studied for organic anion transporter activity by determining intracellular fluo-3 and fura-red accumulation and by measuring fluo-3 efflux. Modulators of organic anion transport systems were used to identify the transporters that are involved in dye extrusion. Addition of probenecid to the dye-loading medium, containing 10 muM fluo-3/AM and fura-red/AM, resulted in a dose-dependent increase in fluo-3 and fura-red accumulation in the cells. The increase in fluo-3 accumulation in the cells in the presence of probenecid was explained by the inhibitory effect of this compound on fluo-3 efflux. Fluo-3 efflux from the cells was also inhibited by sulfinpyra-zone, another inhibitor of organic anion transport. Substrates of renal probenecid-sensitive organic anion exchange mechanisms as well as modulators of multidrug resistance associated protein (MRP) activity did not influence fluo-3 extrusion rates. However, reducing intracellular ATP contents completely blocked fluo-3 extrusion. Moreover, MK571, an inhibitor of MRP, significantly stimulated dye accumulation, whereas inhibitors of the multidrug resistance gene (MDR1) product P-glycoprotein, cyclosporin A and verapamil, did not, As probenecid inhibits fluo-3 efflux across the apical membrane of cells grown on permeable supports, we conclude that a probenecid-sensitive organic anion transporter is present in the apical membrane of HT29 cl.19A cells. This organic anion transport system differs from MDR1 and MRP2.
引用
收藏
页码:529 / 537
页数:9
相关论文
共 48 条
[1]   Drug exsorption from blood into the gastrointestinal tract [J].
Arimori, K ;
Nakano, M .
PHARMACEUTICAL RESEARCH, 1998, 15 (03) :371-376
[2]  
AUGERON C, 1984, CANCER RES, V44, P3961
[3]   FLOW CYTOMETRIC MEASUREMENT OF CALCIUM INFLUX IN MURINE T-CELL HYBRIDS USING FLUO-3 AND AN ORGANIC-ANION TRANSPORT INHIBITOR [J].
BAUS, E ;
URBAIN, J ;
LEO, O ;
ANDRIS, F .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 173 (01) :41-47
[4]   P-glycoproteins and multidrug resistance [J].
Bellamy, WT .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :161-183
[5]   P-glycoprotein multidrug resistance and cancer [J].
Bosch, I ;
Croop, J .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1288 (02) :F37-F54
[6]   How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein [J].
Broxterman, HJ ;
Lankelma, J ;
Pinedo, HM .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :1024-1033
[7]  
Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO
[8]  
2-J
[9]  
Collett A, 1999, J PHARMACOL EXP THER, V288, P171
[10]   Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors [J].
Cormet-Boyaka, E ;
Huneau, JF ;
Mordrelle, A ;
Boyaka, PN ;
Carbon, C ;
Rubinstein, E ;
Tomé, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2607-2611